• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

患者及其医疗服务提供者是否在谈论长效注射抗逆转录病毒疗法？在美国三个医疗场所的临床诊疗中的普及情况。

Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites.

作者信息

Christopoulos Katerina A, Colasanti Jonathan, Johnson Mallory O, Diaz Tsuzuki Manami, Erguera Xavier A, Flores Rey, Kerman Jared, Dance Kaylin, Sauceda John A, Neilands Torsten B, Dilworth Samantha E, Koester Kimberly A, Gutierrez Jose, Schneider John A, Montgomery Elizabeth, McNulty Moira C

机构信息

Division of HIV, ID and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

出版信息

Open Forum Infect Dis. 2022 Jun 11;9(7):ofac293. doi: 10.1093/ofid/ofac293. eCollection 2022 Jul.

DOI:10.1093/ofid/ofac293
PMID:35873299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9301580/
Abstract

Use of long-acting injectable antiretroviral therapy depends on patient awareness, provider discussion, and patient willingness to use. We conducted a postvisit survey with patients at 3 HIV clinics in San Francisco, Chicago, and Atlanta in May 2021 to assess for inequities in these early implementation phases.

摘要

长效注射抗逆转录病毒疗法的使用取决于患者的认知、与医疗服务提供者的讨论以及患者使用的意愿。2021年5月，我们对旧金山、芝加哥和亚特兰大的3家艾滋病诊所的患者进行了随访后调查，以评估这些早期实施阶段中存在的不平等情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d8/9301580/9c4270bb68aa/ofac293f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d8/9301580/4caaec800960/ofac293f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d8/9301580/9c4270bb68aa/ofac293f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d8/9301580/4caaec800960/ofac293f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d8/9301580/9c4270bb68aa/ofac293f2.jpg

相似文献

1
Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites.患者及其医疗服务提供者是否在谈论长效注射抗逆转录病毒疗法？在美国三个医疗场所的临床诊疗中的普及情况。
Open Forum Infect Dis. 2022 Jun 11;9(7):ofac293. doi: 10.1093/ofid/ofac293. eCollection 2022 Jul.
2
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials.长效注射用抗逆转录病毒疗法治疗艾滋病毒感染者的最佳实施的多层次考量：参与3期试验的医疗服务提供者的观点
BMC Health Serv Res. 2021 Mar 20;21(1):255. doi: 10.1186/s12913-021-06214-9.
3
Feasibility of Implementing Long-Acting Injectable Antiretroviral Therapy to Treat HIV: A Survey of Health Providers from the 13 Countries Participating in the ATLAS-2M Trial.实施长效注射抗逆转录病毒疗法治疗艾滋病病毒的可行性：对参与ATLAS - 2M试验的13个国家的医疗服务提供者的调查。
AIDS Res Hum Retroviruses. 2021 Mar;37(3):207-213. doi: 10.1089/AID.2020.0208. Epub 2021 Jan 19.
4
Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco.旧金山开展全市范围的快速抗逆转录病毒治疗计划。
Am J Prev Med. 2021 Nov;61(5 Suppl 1):S47-S54. doi: 10.1016/j.amepre.2021.06.001.
5
A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.美国 HIV 感染者对靶向长效注射型抗逆转录病毒疗法可接受性的联合分析
AIDS Behav. 2020 Apr;24(4):1226-1236. doi: 10.1007/s10461-019-02701-7.
6
Acceptability and feasibility of long-acting injectable antiretroviral therapy for HIV-infected persons who inject drugs in Vietnam: A qualitative study.长效注射用抗逆转录病毒疗法在越南注射毒品的艾滋病毒感染者中的可接受性和可行性：一项定性研究
Lancet Reg Health West Pac. 2022 Sep 23;31:100603. doi: 10.1016/j.lanwpc.2022.100603. eCollection 2023 Feb.
7
Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability.在替代护理点对长效注射型 HIV 抗逆转录病毒治疗的看法：一项对同时存在药物使用和/或住房不稳定问题的 HIV 感染者进行的定性研究。
Harm Reduct J. 2023 Jan 10;20(1):4. doi: 10.1186/s12954-023-00730-z.
8
"I feel empowered": women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain.“我感到有力量”：美国和西班牙的女性对长效注射型抗逆转录病毒疗法的看法和体验。
Cult Health Sex. 2021 Aug;23(8):1066-1078. doi: 10.1080/13691058.2020.1752397. Epub 2020 May 21.
9
HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005.2004年至2005年期间，在亚特兰大、旧金山和洛杉矶被诊断为早期梅毒的男性中的艾滋病毒感染率。
J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):234-40.
10
Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention.用于HIV治疗和预防的长效注射用抗逆转录病毒药物
Infect Chemother. 2021 Dec;53(4):686-695. doi: 10.3947/ic.2021.0136.

引用本文的文献

1
Mode of administration matters: Willingness of people with HIV to switch to future long-acting treatments, and health care professionals' intention to discuss these options.给药方式很重要：HIV感染者改用未来长效治疗方法的意愿，以及医护人员讨论这些选择的意向。
HIV Med. 2025 Sep;26(9):1395-1404. doi: 10.1111/hiv.70066. Epub 2025 Jul 2.
2
Preparing for pharmacy-based delivery of long-acting injectable antiretrovirals: a pre-implementation study.为基于药房的长效注射抗逆转录病毒药物配送做准备：一项实施前研究。
BMC Health Serv Res. 2025 Jun 5;25(1):808. doi: 10.1186/s12913-025-12971-8.
3
Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South.

本文引用的文献

1
The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?长效抗逆转录病毒疗法提高依从性的前景：有哪些数据？
J Int Assoc Provid AIDS Care. 2021 Jan-Dec;20:23259582211009011. doi: 10.1177/23259582211009011.
2
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials.长效注射用抗逆转录病毒疗法治疗艾滋病毒感染者的最佳实施的多层次考量：参与3期试验的医疗服务提供者的观点
BMC Health Serv Res. 2021 Mar 20;21(1):255. doi: 10.1186/s12913-021-06214-9.
3
美国南部两家瑞安·怀特诊所中使用长效注射用卡博特韦/利匹韦林的艾滋病毒感染者的早期实施情况及结果
AIDS Res Hum Retroviruses. 2024 Dec;40(12):690-700. doi: 10.1089/AID.2024.0007. Epub 2024 Jul 16.
4
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy.参与护理、知晓和对长效注射型抗逆转录病毒治疗的兴趣。
AIDS Behav. 2024 Oct;28(10):3315-3325. doi: 10.1007/s10461-024-04423-x. Epub 2024 Jul 1.
5
Likelihood of Trying Long-Acting Injectable Antiretroviral Therapy Among Women With HIV in Nine Sites Across the United States.美国九个地区感染艾滋病毒的女性尝试长效注射抗逆转录病毒疗法的可能性。
J Acquir Immune Defic Syndr. 2024 Jul 1;96(3):e23-e27. doi: 10.1097/QAI.0000000000003422.
6
Low Uptake of Long-Acting Injectables in the First 2.5 Years Following Approval Among a Cohort of People Living With HIV.在一组艾滋病毒感染者中，长效注射剂获批后的头2.5年里使用率较低。
Open Forum Infect Dis. 2024 May 16;11(5):ofae087. doi: 10.1093/ofid/ofae087. eCollection 2024 May.
7
Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United States.在美国三个接受 Ryan White 基金资助的诊所接受治疗的 HIV 感染者对长效注射型抗逆转录病毒治疗的可接受性。
AIDS Behav. 2024 Jul;28(7):2226-2238. doi: 10.1007/s10461-024-04315-0. Epub 2024 Apr 10.
8
"What Is the Benefit?": Perceptions and Preferences for Long-Acting Injectable Antiretroviral Therapy Among People Living With HIV.“有何益处？”：HIV 感染者对长效注射型抗逆转录病毒疗法的认知和偏好。
AIDS Educ Prev. 2023 Dec;35(6):467-483. doi: 10.1521/aeap.2023.35.6.467.
9
Antiviral supramolecular polymeric hydrogels by self-assembly of tenofovir-bearing peptide amphiphiles.基于含替诺福韦的两亲肽自组装的抗病毒超分子聚合物水凝胶。
Biomater Sci. 2023 Jan 17;11(2):489-498. doi: 10.1039/d2bm01649d.
The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review.
长效注射剂即将到来！美国长效注射抗逆转录病毒疗法的实施科学考量：一项范围综述。
AIDS Res Hum Retroviruses. 2021 Feb;37(2):75-88. doi: 10.1089/AID.2020.0126. Epub 2020 Dec 7.
4
Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy.多中心研究：HIV 感染者对长效注射型抗逆转录病毒治疗的认知障碍及接受意向。
J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):263-270. doi: 10.1097/QAI.0000000000002337.
5
"I feel empowered": women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain.“我感到有力量”：美国和西班牙的女性对长效注射型抗逆转录病毒疗法的看法和体验。
Cult Health Sex. 2021 Aug;23(8):1066-1078. doi: 10.1080/13691058.2020.1752397. Epub 2020 May 21.
6
Acceptability and preferences for long-acting antiretroviral formulations among people with HIV infection.接受度和偏好长效抗逆转录病毒制剂在艾滋病毒感染者中的应用。
AIDS Care. 2021 Jun;33(6):801-809. doi: 10.1080/09540121.2020.1764906. Epub 2020 May 14.
7
Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis - United States, 2013-2018.生命体征：2013-2018 年美国人类免疫缺陷病毒检测、病毒抑制和 HIV 暴露前预防状况。
MMWR Morb Mortal Wkly Rep. 2019 Dec 6;68(48):1117-1123. doi: 10.15585/mmwr.mm6848e1.
8
Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV.长效注射型抗逆转录病毒治疗的可接受性和偏好：一项在美国医护人员、HIV 感染者成人和 HIV 感染青年父母中开展的定性研究。
AIDS Patient Care STDS. 2019 Mar;33(3):104-111. doi: 10.1089/apc.2018.0198.
9
Interest of Youth Living With HIV in Long-Acting Antiretrovirals.青少年对长效抗逆转录病毒药物的兴趣。
J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):190-197. doi: 10.1097/QAI.0000000000001896.
10
HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016.HIV 暴露前预防，按种族和族裔划分-美国，2014-2016 年。
MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1147-1150. doi: 10.15585/mmwr.mm6741a3.